Desh Rakshak Aushdhalaya Limited (BOM:531521)
35.00
-1.61 (-4.40%)
At close: May 29, 2026
Desh Rakshak Aushdhalaya Revenue
In the fiscal year ending March 31, 2026, Desh Rakshak Aushdhalaya had annual revenue of 71.04M INR with 13.30% growth. Desh Rakshak Aushdhalaya had revenue of 34.53M in the quarter ending March 31, 2026, with 62.83% growth.
Revenue
71.04M
Revenue Growth
+13.30%
P/S Ratio
2.81
Revenue / Employee
3.55M
Employees
20
Market Cap
199.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 71.04M | 8.34M | 13.30% |
| Mar 31, 2025 | 62.71M | 2.63M | 4.37% |
| Mar 31, 2024 | 60.08M | -1.72M | -2.79% |
| Mar 31, 2023 | 61.80M | -91.20K | -0.15% |
| Mar 31, 2022 | 61.89M | -4.09M | -6.19% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.55B |
| Walpar Nutritions | 757.46M |
| Gujarat Terce Laboratories | 474.73M |
| Cian Healthcare | 232.80M |
| Zenith Healthcare | 105.22M |
| Hamps Bio | 88.07M |
| Norris Medicines | 81.32M |
| Colinz Laboratories | 61.36M |